Search results
Results from the WOW.Com Content Network
A 2010 Cochrane review found that men taking finasteride for BPH (with a mean age of 62.4) are at increased risk for impotence, erectile dysfunction (ED), decreased libido, and ejaculation disorder for the first year of treatment. The rates became indistinguishable from placebo after 2–4 years and these side effects usually got better over time.
But oral finasteride has known side effects like decreased arousal and ED from the oral tablet, so using a topical finasteride treatment could be a preferable alternative for some people.
Finasteride can bring some side effects, but that’s true with any medication, Dr. Bhanusali says. While the risk of side effects is low and most men don’t experience any, doctors educate ...
Unlike regular finasteride side effects, the adverse reactions associated with post-finasteride syndrome can continue after someone stops taking it. Some men with PFS report symptoms that last for ...
Of course, like any medication, topical finasteride has potential side effects. Most often, side effects of topical finasteride are minimal and often occur where the product is applied. The most ...
Most men who take finasteride won’t experience any side effects, though. Clinical trials found that 1.8 percent of men who took finasteride experienced decreased drive compared to 1.3 percent of ...
The side effects of cyproterone acetate (CPA), a steroidal antiandrogen and progestin, including its frequent and rare side effects, have been studied and characterized.It is generally well-tolerated and has a mild side-effect profile, regardless of dosage, when it used as a progestin or antiandrogen in combination with an estrogen such as ethinylestradiol or estradiol valerate in women.
These side effects may occur in as many as 90% of men treated with bicalutamide monotherapy, [29] but gynecomastia is generally reported to occur in 70 to 80% of patients. [30] In the EPC trial, at a median follow-up of 7.4 years, breast pain and gynecomastia respectively occurred in 73.6% and 68.8% of men treated with 150 mg/day bicalutamide ...